RECK expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.148800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.150800E-01
Normal-vs-Stage2
6.020600E-01
Normal-vs-Stage3
3.463200E-01
Normal-vs-Stage4
5.785600E-01
Stage1-vs-Stage2
9.210400E-01
Stage1-vs-Stage3
6.263600E-01
Stage1-vs-Stage4
2.711600E-01
Stage2-vs-Stage3
7.198400E-01
Stage2-vs-Stage4
1.081370E-01
Stage3-vs-Stage4
2.310800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.866600E-01
Normal-vs-AfricanAmerican
9.795000E-01
Normal-vs-Asian
3.820800E-01
Caucasian-vs-AfricanAmerican
4.980400E-01
Caucasian-vs-Asian
4.491400E-01
AfricanAmerican-vs-Asian
4.136200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.428200E-01
Normal-vs-Female
7.286400E-01
Male-vs-Female
2.570400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.055000E-01
Normal-vs-Age(41-60Yrs)
8.889600E-01
Normal-vs-Age(61-80Yrs)
5.313400E-01
Normal-vs-Age(81-100Yrs)
2.356400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.576800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.754000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.407600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.645900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.516020E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.529800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.462600E-01
Normal-vs-Daily Drinker
5.926000E-02
Normal-vs-Weekly Drinker
6.435200E-01
Normal-vs-Occasional Drinker
4.208800E-01
Normal-vs-Social Drinker
9.635800E-01
Non Drinker-vs-Daily Drinker
3.292400E-01
Non Drinker-vs-Weekly Drinker
5.080000E-01
Non Drinker-vs-Occasional Drinker
8.665800E-01
Non Drinker-vs-Social Drinker
1.860000E-01
Daily Drinker-vs-Weekly Drinker
7.844000E-02
Daily Drinker-vs-Occasional Drinker
2.318200E-01
Daily Drinker-vs-Social Drinker
8.522300E-02
Weekly Drinker-vs-Occasional Drinker
5.944000E-01
Weekly Drinker-vs-Social Drinker
5.198400E-01
Occasional Drinker-vs-Social Drinker
2.941600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.313000E-01
Normal-vs-Grade 2
5.546000E-01
Normal-vs-Grade 3
6.795400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.208800E-01
Grade 1-vs-Grade 3
8.200600E-01
Grade 1-vs-Grade 4
7.313000E-01
Grade 2-vs-Grade 3
3.713800E-01
Grade 2-vs-Grade 4
5.546000E-01
Grade 3-vs-Grade 4
6.795400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.633800E-01
Normal-vs-NonDiabetic
4.999800E-01
Diabetic-vs-NonDiabetic
9.308000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.690100E-02
Normal-vs-NoPancreatitis
5.822400E-01
Pancreatitis-vs-NoPancreatitis
1.866170E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.442200E-01
Normal-vs-N1
6.040600E-01
N0-vs-N1
9.507600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.920400E-01
Normal-vs-TP53-NonMutant
8.041400E-01
TP53-Mutant-vs-TP53-NonMutant
2.805800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
